The debate over the intensity of blood pressure
(BP) lowering for patients with hypertension has been going on for decades. Additional fuel to the fire was recently added
with the early halt and publication of the Systolic Blood Pressure Intervention
Trial (SPRINT). So “how low should
you go” for patients with high BP? Do lower BP goals reduce CV outcomes and
death, particularly in patients at high risk?
Do they cause greater adverse effects? Or perhaps even worsen CV outcomes?
These questions were examined in SPRINT.